Correction to: double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol (Trials, (2022), 23, 1, (19), 10.1186/s13063-021-05951-w)

Authors
Category Primary study
JournalTrials
Year 2022
Following the publication of the original article [1], we were notified that the author names have been incorrectly tagged (part of the last names had originally been tagged as first name).
Epistemonikos ID: 5cecb540a422550223f4fdc8cb602b310e47e511
First added on: Dec 20, 2022